Get the Stockscreener App
0.90
5.26%
-0.05
After Hours:
.91
0.01
+1.11%
Cypherpunk Technologies Inc stock is traded at $0.90, with a volume of 2.41M.
It is down -5.26% in the last 24 hours and up +55.17% over the past month.
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
See More
Previous Close:
$0.95
Open:
$0.94
24h Volume:
2.41M
Relative Volume:
0.96
Market Cap:
$80.98M
Revenue:
-
Net Income/Loss:
$4.82M
P/E Ratio:
13.27
EPS:
0.0678
Net Cash Flow:
$-140.90M
1W Performance:
+11.48%
1M Performance:
+55.17%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.871
$0.9694
1-Week Range:
$0.75
$1.14
52-Week Range:
$0.50
$3.6999
Cypherpunk Technologies Inc Stock (CYPH) Company Profile
Name
Cypherpunk Technologies Inc
Sector
Industry
Phone
617 252 4343
Address
47 THORNDIKE STREET, CAMBRIDGE
Compare CYPH vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CYPH
Cypherpunk Technologies Inc
|
0.90 | 85.48M | 0 | 4.82M | -140.90M | 0.0678 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cypherpunk Technologies Inc Stock (CYPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-29-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-28-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-04-21 | Initiated | Mizuho | Buy |
| Jun-04-21 | Resumed | Robert W. Baird | Outperform |
| Jun-29-20 | Initiated | Piper Sandler | Overweight |
| Feb-11-20 | Initiated | Robert W. Baird | Outperform |
| Nov-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-13-19 | Resumed | Raymond James | Outperform |
| Mar-07-17 | Initiated | Ladenburg Thalmann | Buy |
View All
Cypherpunk Technologies Inc Stock (CYPH) Latest News
Cypherpunk Technologies Expands ZEC Holdings with New Purchase - GuruFocus
Cypherpunk Technologies Acquires New ZEC and Launches New Website - Intellectia AI
Cypherpunk Increases its Zcash Stake, Launches New Website and Investor Dashboard - PR Newswire
Cypherpunk Technologies Inc. Files Form 8-K with SEC – Company Details, Stock Symbol, and NASDAQ Listing Information - Minichart
Cypherpunk Technologies announces retirement of four board members ahead of annual meeting By Investing.com - Investing.com Australia
Cypherpunk Technologies announces retirement of four board members ahead of annual meeting - Investing.com Australia
Cypherpunk's ZODL Investment: A Tactical Bet to Turn Around Zcash's Decline - Bitget
Cypherpunk Technologies Announces Planned Board Leadership Transitions - TipRanks
Four Cypherpunk (CYPH) directors set to retire at 2026 meeting - Stock Titan
9 Health Care Stocks Moving In Wednesday's Pre-Market Session - Sahm
Top Cypherpunk Technologies (CYPH) Competitors 2026 - MarketBeat
CYPH SEC FilingsCypherpunk Technologies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
CYPH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CYPH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
CYPHERPUNK (CYPH) director sells 60K shares to cover RSU taxes - Stock Titan
[144] CYPHERPUNK TECHNOLOGIES INC. SEC Filing - Stock Titan
Leap Therapeutics Stock More Than Doubles On Zcash Treasury Pivot – Former POTUS Advisor Calls It ‘Gangster’ Move - MSN
Cypherpunk Technologies restructures CoinXit equity compensation agreement - MSN
CYPH.O Technical Analysis & Stock Price Forecast - Intellectia AI
Cypherpunk Technologies Inc. - AD HOC NEWS
Cypherpunk Technologies (CYPH) Stock Forecast and Price Target 2026 - MarketBeat
Cypherpunk Technologies (CYPH) director converts 104,500 RSUs to 152,500 share stake - Stock Titan
Cypherpunk (CYPH) director converts 168,750 vested RSUs into common stock - Stock Titan
Director at Cypherpunk (CYPH) receives 168,750 shares from RSUs - Stock Titan
Director William Li of Cypherpunk (CYPH) receives 168,750 shares from RSU settlements - Stock Titan
RSU settlements give Cypherpunk (CYPH) director 168,750 common shares - Stock Titan
Cypherpunk Technologies (CYPH) director converts 168,750 RSUs into common shares - Stock Titan
Cypherpunk (CYPH) director converts 168,750 RSUs into common stock - Stock Titan
Director at Cypherpunk (CYPH) gains 168,750 shares via RSU settlements - Stock Titan
Director Loscalzo acquires 168,750 Cypherpunk (CYPH) shares via RSUs - Stock Titan
Director Cavanaugh acquires 168,750 Cypherpunk (CYPH) shares from RSUs - Stock Titan
ZEC Rallies 20% After Cypherpunk Reports First Annual Profit - thedefiant.io
CYPH.O PE Ratio & Valuation, Is CYPH.O Overvalued - Intellectia AI
CYPH.O Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
CYPH.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CYPH Should I Buy - Intellectia AI
CYPH.O Forecast — Price Prediction for 2026. Should I Buy CYPH.O? - Intellectia AI
Cypherpunk Technologies Inc. (Formerly Leap Therapeutics) Combines Digital Privacy Tech and Cancer Drug Development – 2025 Annual Report Overview - Minichart
Security Notice: Cysic Foundation X Account Breached - Bitget
Cypherpunk reports full year 2025 financial results - marketscreener.com
Cypherpunk Reports Full Year 2025 Financial Results - National Today
Cypherpunk Technologies Reports Transformational 2025 Financial Results - Intellectia AI
Cypherpunk Technologies 10-K: Revenue $0, EPS $0.07 on $4.8M Net Income - TradingView
CYPH: 2025 saw a strategic pivot to Zcash, a return to profitability, and major digital asset gains - TradingView
Cypherpunk Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cypherpunk Technologies (CYPH) pivots to Zcash while advancing cancer drugs - Stock Titan
CYPH: Returned to profitability in 2025 with strong ZEC gains, new capital, and clinical progress - TradingView
[8-K] CYPHERPUNK TECHNOLOGIES INC. Reports Material Event | CYPH SEC FilingForm 8-K - Stock Titan
Cypherpunk Technologies Inc. (CYPH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cypherpunk Technologies Receives Nasdaq Minimum Bid Price Notice - The Globe and Mail
Cypherpunk Technologies Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Cypherpunk Technologies Inc Stock (CYPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):